Dr. Arindam (“Arin”) Bose is Akero’s Vice President for Drug Substance Process Development. Arin retired from Pfizer Research & Development in 2016 after 34 years in leadership roles in bioprocess development and clinical manufacturing. For the last six years of his Pfizer tenure, Arin served as Vice-President, Biotherapeutics Pharmaceutical Sciences External Affairs and Biosimilar Strategy with responsibility for external sourcing, competitive intelligence and external influencing, as well as for executing the technical development plan for Pfizer’s entry into biosimilars. He was a member of the Bioprocess Leadership Team (BPLT) – Pfizer’s most senior oversight body for technical development and manufacturing of biotechnology products.
Arin is widely recognized as a Key Thought Leader in the biopharmaceutical industry. He has served as the Chair of the Biologics and Biotechnology Leadership Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA), the chief advocacy arm of the US pharmaceutical industry. He was elected to the US National Academy of Engineering for innovations in biomanufacturing. Arin received a Ph.D. in chemical engineering from Purdue University, M.S. from the University of Michigan, Ann Arbor and B. Tech from the Indian Institute of Technology, Kanpur.